Ascletis Pharma Stock Price on April 8, 2024
| ASCLF Stock | USD 0.16 0.00 0.00% |
If you're considering investing in Ascletis Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Ascletis Pharma stands at 0.16, as last reported on the 30th of October, with the highest price reaching 0.16 and the lowest price hitting 0.16 during the day. At this point, Ascletis Pharma is out of control. Ascletis Pharma secures Sharpe Ratio (or Efficiency) of 0.064, which signifies that the company had a 0.064% return per unit of standard deviation over the last 3 months. We have found seventeen technical indicators for Ascletis Pharma, which you can use to evaluate the volatility of the firm. Please confirm Ascletis Pharma's risk adjusted performance of 0.0536, and Mean Deviation of 0.4006 to double-check if the risk estimate we provide is consistent with the expected return of 0.12%.
Ascletis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Ascletis |
Sharpe Ratio = 0.064
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ASCLF | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.85 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 5 95% of assets perform better |
Based on monthly moving average Ascletis Pharma is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascletis Pharma by adding it to a well-diversified portfolio.
Ascletis Pharma Valuation on April 8, 2024
It is possible to determine the worth of Ascletis Pharma on a given historical date. On April 8, 2024 Ascletis was worth 0.2 at the beginning of the trading date compared to the closed value of 0.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ascletis Pharma pink sheet. Still, in general, we apply an absolute valuation method to find Ascletis Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ascletis Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ascletis Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.20 | 0.20 | 0.20 | 0.20 | 1.00 | |
04/08/2024 | 0.20 | 0.20 | 0.20 | 0.20 | 1.00 |
| 0.20 | 0.20 | 0.20 | 0.20 | 1.00 |
| Backtest Ascletis Pharma | | | Ascletis Pharma History | | | Ascletis Pharma Valuation | Previous | Next |
Ascletis Pharma Trading Date Momentum on April 8, 2024
| On April 09 2024 Ascletis Pharma was traded for 0.20 at the closing time. The highest daily price throughout the period was 0.20 and the lowest price was 0.20 . There was no trading activity during the period 1.0. Lack of trading volume on 04/09/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Ascletis Pharma Fundamentals Correlations and Trends
By evaluating Ascletis Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ascletis Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ascletis financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ascletis Pharma Pink Sheet history
Ascletis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascletis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascletis Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascletis Pharma stock prices may prove useful in developing a viable investing in Ascletis Pharma
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer ASC61 and ASC63 for advanced solid tumors ASC60 to treat solid tumors and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the Peoples Republic of China. Ascletis Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 266 people.
Ascletis Pharma Pink Sheet Technical Analysis
Ascletis Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Ascletis Pharma Period Price Range
Low | October 30, 2024
| High |
0.00 | 0.00 |
Ascletis Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ascletis Pharma October 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Ascletis Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ascletis Pharma shares will generate the highest return on investment. By undertsting and applying Ascletis Pharma pink sheet market strength indicators, traders can identify Ascletis Pharma entry and exit signals to maximize returns
Ascletis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascletis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascletis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascletis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0536 | |||
| Jensen Alpha | 0.0726 | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | 0.1866 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ascletis Pink Sheet analysis
When running Ascletis Pharma's price analysis, check to measure Ascletis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascletis Pharma is operating at the current time. Most of Ascletis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascletis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascletis Pharma's price. Additionally, you may evaluate how the addition of Ascletis Pharma to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |